OTCMKTS:GTHP Guided Therapeutics (GTHP) Stock Price, News & Analysis $0.20 +0.02 (+11.11%) As of 03:19 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About Guided Therapeutics Stock (OTCMKTS:GTHP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Guided Therapeutics alerts:Sign Up Key Stats Today's Range$0.19▼$0.2550-Day Range$0.18▼$0.3052-Week Range$0.15▼$0.54Volume23,500 shsAverage Volume44,475 shsMarket Capitalization$19.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Guided Therapeutics, Inc. is a medical technology company focused on developing diagnostic products for the detection of cancer and precancerous conditions. Its technology is based on biophotonic tissue analysis, which uses light to identify changes in tissue that may be associated with disease. The company’s principal product is LuViva Advanced Cervical Scan, a noninvasive diagnostic device designed to evaluate cervical tissue for abnormalities associated with cervical cancer and precancer. The system is intended to provide clinicians with information during an office visit and may help reduce reliance on more invasive diagnostic procedures such as tissue biopsies. Guided Therapeutics has also explored applications of its platform in other areas of cancer detection. Guided Therapeutics is headquartered in Norcross, Georgia, and has pursued regulatory and commercial opportunities in the United States and international markets. The company’s leadership has included Gene Cartwright, who has served as president and chief executive officer. Product availability and regulatory status may vary by geography and are subject to applicable approvals.AI Generated. May Contain Errors. Read More Guided Therapeutics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreGTHP MarketRank™: Guided Therapeutics scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Guided Therapeutics. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Guided Therapeutics is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Guided Therapeutics is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.02% of the float of Guided Therapeutics has been sold short.Short Interest Ratio / Days to CoverGuided Therapeutics has a short interest ratio ("days to cover") of 0.35, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Guided Therapeutics has recently increased by 55.05%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuided Therapeutics does not currently pay a dividend.Dividend GrowthGuided Therapeutics does not have a long track record of dividend growth. News and Social Media1.6 / 5News SentimentN/A News SentimentGuided Therapeutics has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Guided Therapeutics this week, compared to 0 articles on an average week.Search Interest1 people have searched for GTHP on MarketBeat in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Guided Therapeutics insiders have not sold or bought any company stock.Percentage Held by Insiders66.83% of the stock of Guided Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions9.69% of the stock of Guided Therapeutics is held by institutions.Read more about Guided Therapeutics' insider trading history. Receive GTHP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GTHP Stock News HeadlinesGuided Therapeutics (OTCMKTS:GTHP) Stock Price Up 0.8% - Time to Buy?September 22, 2026 | americanbankingnews.comGuided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical CancerSeptember 9, 2026 | finance.yahoo.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 29 at 1:00 AM | Banyan Hill Publishing (Ad)Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese DistributorJuly 22, 2026 | finance.yahoo.comGuided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments CorporationJuly 14, 2026 | uk.finance.yahoo.comGuided Therapeutics Files Premarket Approval Application Clinical Report with FDAJune 16, 2026 | businesswire.comGuided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant OfferingMarch 31, 2026 | finance.yahoo.comAnalysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuVivaDecember 17, 2025 | finance.yahoo.comSee More Headlines GTHP Stock Analysis - Frequently Asked Questions How have GTHP shares performed this year? Guided Therapeutics' stock was trading at $0.54 at the beginning of the year. Since then, GTHP shares have decreased by 63.0% and is now trading at $0.20. How were Guided Therapeutics' earnings last quarter? Guided Therapeutics Inc. (OTCMKTS:GTHP) issued its quarterly earnings data on Thursday, August, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. How do I buy shares of Guided Therapeutics? Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guided Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guided Therapeutics investors own include Cornerstone Strategic Investment Fund (CLM), Intel (INTC), Beam Therapeutics (BEAM), ChargePoint (CHPT), CSX (CSX), Enbridge (ENB). Company Calendar Last Earnings8/13/2026Today9/29/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:GTHP CIK924515 Webwww.guidedinc.com Phone(770) 242-8723Fax770-242-8639Employees5Year Founded1992Profitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.20 million Net MarginsN/A Pretax Margin-471.23% Return on EquityN/A Return on Assets-243.93% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick RatioN/A Sales & Book Value Annual Sales$770 thousand Price / Sales25.08 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-2.22Miscellaneous Outstanding Shares96,540,000Free Float32,021,000Market Cap$19.31 million OptionableNot Optionable Beta0.69 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:GTHP) was last updated on 9/29/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
